داروهای ضدانعقاد، ضدپلاکت ها، و ترومبولیتیک ها ۲۰۱۰
Anticoagulants, Antiplatelets, and Thrombolytics 2010

1. In vitro Methods of Evaluating Antithrombotics and Thrombolytics Shaker A. Mousa 2. In vivo Models for the Evaluation of Antithrombotics and Thrombolytics Shaker A. Mousa 3. Heparin and Low Molecular Weight Heparins in Thrombosis and Beyond Shaker A. Mousa 4. Laboratory Methods and Management of Patients with Heparin-Induced Thrombocytopenia Margaret Prechel, Walter P. Jeske, and Jeanine M. Walenga 5. Novel Anticoagulant Therapy: Principle and Practice Shaker A. Mousa 6. Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban Shaker A. Mousa 7. Antiplatelet Therapies: Drug Interactions in the Management of Vascular Disorders Shaker A. Mousa 8. Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist Shaker A. Mousa, Walter P. Jeske, and Jawed Fareed 9. Antithrombotic Effects of Naturally Derived Products on Coagulation and Platelet Function Shaker A. Mousa 10. Assessment of Anti-Metastatic Effects of Anticoagulant and Antiplatelet Agents Using Animal Models of Experimental Lung Metastasis Ali Amirkhosravi, Shaker A. Mousa, Mildred Amaya, Todd Meyer, Monica Davila, Theresa Robson, and John L. Francis 11. Adhesion Molecules: Potential Therapeutic & Diagnostic Implications Shaker A. Mousa 12. Pharmacogenomics in Thrombosis Shaker A. Mousa 13. Diagnosis and Management of Sickle Cell Disorders Shaker A. Mousa and Mohamad H. Qari